This inventor holds 2 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignees: Beijing University of Technology, Hudson Institute of Medical Research, Monash University. Active years: 2021-2025.
Company Filing History:
1 out of 388 
1 out of 10 
1 out of 18 Years Active: 2021-2025
Title: Claudia Nold - Innovator in Anti-Inflammatory Therapeutics
Introduction
Claudia Nold is a prominent inventor based in Clayton, Australia. She has made significant contributions to the field of biomedical research, particularly in the development of anti-inflammatory therapeutics. Her work focuses on innovative polypeptides that have the potential to treat various inflammatory diseases.
Latest Patents
Claudia Nold holds 1 patent for her invention related to IL-37 variants. This invention pertains to polypeptides, including variants of interleukin-37 (IL-37), and encompasses related therapeutics and compositions. The invention also details the use of these polypeptides and compositions in methods aimed at treating inflammatory diseases or conditions. Notably, her invention provides a monomeric anti-inflammatory polypeptide that comprises an amino acid sequence of an IL-37 monomer, with specific mutations or modifications to prevent the anti-inflammatory peptide from forming a homodimer.
Career Highlights
Throughout her career, Claudia has worked with esteemed institutions such as Beijing University of Technology and the Hudson Institute of Medical Research. Her research has been pivotal in advancing the understanding of inflammatory responses and developing novel therapeutic strategies.
Collaborations
Claudia has collaborated with notable colleagues, including Marcel Nold and Andrew Ellisdon. These partnerships have enriched her research and contributed to the success of her innovative projects.
Conclusion
Claudia Nold's contributions to the field of anti-inflammatory therapeutics highlight her role as a leading inventor. Her work on IL-37 variants showcases the potential for innovative treatments in managing inflammatory diseases.